Objectives. The indications for neck dissection concurrent with salvage laryngectomy in the clinically N0 setting remain unclear. Our goals were to determine the prevalence of occult nodal disease, analyze nodal disease distribution patterns, and identify predictors of occult nodal disease in a salvage laryngectomy cohort.
I nformed by the Veterans Affairs Larynx Trial and subsequent multi-institutional studies, [1] [2] [3] [4] nonsurgical regimens designed to achieve organ preservation for advanced-stage laryngeal squamous cell carcinoma (LSCC) have become an accepted standard of care as an alternative to primary laryngectomy. 5 For patients with recurrent LSCC after initial radiation therapy or chemoradiation, salvage laryngectomy is frequently necessary to achieve cure. 6 The decision to perform concurrent neck dissection with salvage laryngectomy remains a subject of debate. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] The overall prevalence of nodal metastasis, while well described by Shah and colleagues in previously untreated patients, 19 is not well described in the salvage setting. For patients with clinically evident persistent or recurrent regional metastases, the need to perform salvage neck dissection is accepted and felt to justify the morbidity and associated risks. However, there are a proportion of patients who have occult positive nodal disease (clinically N0 [cN0] , pathologic N positive [pN1]). In many patients, this is the case despite receiving radiation treatment to the neck and having normal preoperative imaging. Without neck dissection, these patients would have significant risk of treatment failure. Finally, our ability to risk-stratify cN0 patients with recurrent primary disease based on their probability of occult nodal positivity remains poor. Identification of discrete risk groups could help determine which patients may most benefit from elective neck dissection in the salvage setting.
At the University of Michigan, the majority of patients with LSCC who present with recurrent primary site disease and are cN0 routinely undergo concurrent selective neck dissection with salvage laryngectomy. Our primary goal was to examine the prevalence and distribution of nodal disease in salvage laryngectomy patients within our cohort. Additionally, we assessed occult nodal disease prevalence and clinical factors that may indicate increased risk of occult neck disease in our cohort. Finally, we sought to identify predictors of occult nodal disease within this cohort.
Methods

Study Population
We performed a single-institution retrospective case series informed by a prospectively maintained database of patients with head and neck cancer (University of Michigan Institutional Review Board approval HUM00081554). Inclusion criteria specified patients who underwent salvage laryngectomy with neck dissection between 1997 and 2014 for persistent or recurrent LSCC after radiation/chemoradiation therapy failure ( Figure 1) . Surgical failures were excluded for this study, because they would typically have other options for treatment, including further laryngeal surgery or radiation. Demographics, initial and recurrent clinical T classification and N classification, primary treatment modality, levels of neck dissections, and pathologic recurrent T and N classification were tabulated. Recurrent clinical stage was determined by clinical examination notes, which included preoperative imaging (computed tomography [CT], positron emission tomography [PET], and/or magnetic resonance imaging [MRI]) in all patients (78% CT, 12% PET, 9% CT 1 PET, 1% MRI). Patients were staged in accordance to the seventh edition of the American Joint Committee on Cancer's staging system. 20 Overall, we identified 233 patients, with 30 presenting with clinical nodal disease (cN1) and 203 who were cN0. Patient demographic information is shown in Table 1 .
Statistical Analysis
Bivariate associations among clinical variables were tested with nonparametric tests (ie, Fisher's exact test, chi-square test with Monte Carlo estimates for error terms). SPSS 22 (IBM, Armonk, New York) was used to perform statistical analyses. All statistical tests of significance were 2-sided with a of 0.05.
Results
Overall Prevalence of Nodal Disease
The overall prevalence of pN1 disease in our cohort (cN1 and cN0) was 24% (n = 57). Figure 2 shows the distribution and prevalence of nodal disease in recurrent supraglottic and glottic LSCC. There were 29 patients with ipsilateral disease, 8 with contralateral disease, and 20 with bilateral disease. Overall, the recurrent pathologic N classification in this cohort was 176 N0, 20 N1, 0 N2a, 8 N2b, 28 N2c, and 1 N3.
Patients who presented with recurrent cN1 disease were significantly more likely to have cN1 at diagnosis prior to initial treatment ( Table 1 ; P = .0000001) and to be current smokers (P = .01).
Of those with cN1 disease at the time of their recurrence, 73% had pN1 disease confirmed (22 of 30). Initial advanced overall stage and initial treatment with chemoradiation therapy had P values of .06 and .07, respectively, in regard to recurrent cN1 disease. There were no other identifiable patient factors that correlated with recurrent cN1 disease ( Table 1 ; age, sex, ethnicity, T and overall stage, tumor subsite, time from initial treatment to disease recurrence, and initial treatment).
Next, the rate of occult nodal positivity in recurrent cN0 LSCC patients was examined (n = 203). Overall, 35 patients who were recurrent cN0 had pathologic occult nodal disease (17%; Table 2 ).
Distribution of Nodal Disease
Overall, supraglottic tumors had the highest prevalence of nodal positivity in ipsilateral levels II and III and paratracheal nodal basins (17%, 16%, and 15%, respectively; Figure  2A ). Contralateral level II nodal disease was seen in 15% of patients with supraglottic LSCC. The remaining neck levels were demonstrated to have \10% nodal positivity rates.
Glottic tumors had a different pattern of nodal disease ( Figure 2B ). Nodal disease was most frequently identified in the ipsilateral and contralateral paratracheal nodes (11% and 9%, respectively). Level II and III disease was less prevalent in glottic tumors than in supraglottic tumors (5% nodal positivity in ipsilateral and contralateral levels II and III).
Predictors of Occult Nodal Disease
We next evaluated for potential predictors of occult nodal positivity in patients with recurrent LSCC undergoing salvage surgery. We assessed initial tumor stage (T, N, and overall), initial treatment type, time to recurrence, and recurrent tumor subsite and T stage for correlation with occult nodal positivity ( Table 3) . Clinical predictors of occult nodal disease on univariate analysis were recurrent supraglottic subsite (28% vs 10%; P = .0006) and recurrent T4 stage (34% vs 12%; P = .0003).
On bivariate analysis stratifying tumor subsite and T stage, recurrent supraglottic T4 status was a significant predictor of occult nodal disease (50% vs 13%; P = .000006). Other clinical factors (including initial stage, initial nodal status, initial treatment, and time to recurrence) did not predict occult nodal positivity. 
Comparison of Occult Nodal Disease Rates to Literature
We next compared our findings with other studies documenting occult nodal rates in salvage laryngectomy patients. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Overall, 11 studies were identified, with a total of 537 patients. Occult nodal positivity rates ranged from 0% to 30% across these studies, with a combined average of 17% ( Table 4 ).
Discussion
In our cohort, we identified an overall nodal burden rate of 24% (57 of 233 patients), suggesting that nodal disease is relatively common in the salvage larynx cohort. The cN1 cohort certainly warrants neck dissection in conjunction with salvage laryngectomy, as the majority will have pathologic nodal disease confirmed. However, these patients make up only a small proportion of patients needing salvage laryngectomy (13% in our series; 30 of 233). Whether to perform selective neck dissections in cN0 salvage laryngectomy cases remains contested. In our cohort, we found a prevalence of 17% occult nodal disease in cN0 necks, which is consistent with the average of rates found by other groups. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Notably in most studies, preoperative imaging was not standardized, which potentially confounds occult nodal rates.
Historically, neck dissection is suggested if risk of nodal disease is greater than 15% to 20%. [21] [22] [23] In our cohort, overall occult nodal positivity rate was 17%, suggesting potential benefit for elective neck dissections in some salvage laryngectomy patients. For many of these patients, subsequent recurrences after salvage laryngectomy may not be resectable. The risk of nodal metastasis was significantly higher in clinically T4 patients and patients with recurrent disease of the supraglottis; given their high rates of occult nodal disease (34% and 28%, respectively), elective neck dissection is a strong consideration in these cases. Notably, risk of occult nodal disease should still be considered in lower T stages, as rates are still 12% in T1-3 tumors. Interestingly, in our cohort, initial disease factors (including initial stage [T, N, overall], subsite, and therapy rendered) did not predict occult nodal disease.
The main rationale to avoid neck dissection concurrent with salvage laryngectomy in the cN0 setting is the increased morbidity and potential complications, including fistula/wound healing 24, 25 and hypocalcemia. 26 Pretreatment radiation fields significantly increase the risk of complications among this cohort. The addition of regional and free tissue augmentation has mitigated some of these risks in salvage laryngectomy, but they are not without consequence. As with all decisions, the proportionality of risks and benefits need to be weighed appropriately in light of the best clinical data along with surgeon and patient preference.
It is challenging to determine which levels to include in elective neck dissection among patients with recurrent LSCC. Currently, elective neck dissection for LSCC generally includes levels II to IV. 19, 27 In our cohort, recurrent supraglottic tumors had a sufficiently high percentage of ipsilateral and contralateral level II and III positive nodal disease (respectively, level II: 17% and 16%; level III: 15%
and 10%) and ipsilateral paratracheal (15%) nodal disease to warrant inclusion of these levels in any patients undergoing elective neck dissection. Inclusion of bilateral level II and III nodes for supraglottic tumors addresses the majority of nodal disease. For glottic tumors, we most frequently identified ipsilateral and contralateral paratracheal nodal disease (11% and 9%, respectively). Interestingly, most other salvage laryngectomy studies did not specifically investigate occult nodal disease in the paratracheal basins. In these patients, inclusion of the bilateral paratracheal nodes in elective neck dissection should be considered.
Our study has some limitations. Namely, we did not have access to complete outside records of radiation fields or initial imaging in many cases. Initial radiation fields to the lateral neck could have an effect on subsequent occult nodal disease. Further follow-up analysis and prospective studies of the association of elective neck radiation fields and doses may inform radiation paradigms for primary treatment of LSCC. Although all patients in our cohort had preoperative imaging with CT, PET, or MRI, this was not standardized. Additionally, radiographic analysis of paratracheal nodes can be challenging. Future studies assessing the sensitivity, specificity, and predictive values comparing these preoperative imaging modalities may provide valuable information to the ideal preoperative imaging in this cohort.
Conclusion
The incidence of and risk factors for occult nodal disease among patients undergoing salvage laryngectomy are critical considerations when determining indications for concurrent neck dissection in this setting. Overall, clinically negative necks were pathologically positive in 17% of patients, which should help surgeons in operative planning and is consistent with prior published findings. Patients with advanced recurrent T classification and with tumors involving the supraglottic larynx appear to have higher rates of occult nodal disease. Given our findings, we recommend selective neck dissection for T4 tumors and supraglottic tumors. The distribution of nodal disease by neck level varies per laryngeal subsite and should be taken into account when planning elective neck dissection in the salvage setting. Inclusion of bilateral levels II and III in supraglottic tumors and bilateral paratracheal nodes in glottic tumors may be warranted in these cases. 
